Immune Checkpoint Inhibitors in Acute Myeloid Leukemia: Novel Combinations and Therapeutic Targets Maximilian StahlAaron D. Goldberg Leukemia (A Aguayo, Section Editor) 23 March 2019 Article: 37
Targeting Barriers of Systems of Care in a Growing Multi-disciplinary Field Tolulope A. AgunbiadeYvonne OttavianoAna Barac Cardio-oncology (EH Yang, Section Editor) 11 March 2019 Article: 36
Updates on Hematologic Malignancies in the Older Adult: Focus on Acute Myeloid Leukemia, Chronic Lymphocytic Leukemia, and Multiple Myeloma Li-Wen HuangSandy W. WongRebecca L. Olin Geriatric Oncology (AR MacKenzie, Section Editor) 08 March 2019 Article: 35
Current Status and Future Directions of Immunotherapy in Renal Cell Carcinoma Bryden ConsidineMichael E. Hurwitz Genitourinary Cancers (DP Petrylak and JW Kim, Section Editors) 08 March 2019 Article: 34
Management of Ductal Carcinoma In Situ (DCIS) of the Breast: Present Approaches and Future Directions Lawrence J. Solin Breast Cancer (B Overmoyer, Section Editor) 05 March 2019 Article: 33
Cancer Biomarkers for Integrative Oncology Aniruddha GangulyDavid FrankEdward Chu Integrative Care (C Lammersfeld, Section Editor) 05 March 2019 Article: 32
Novel Imaging in Detection of Metastatic Prostate Cancer Clayton P. SmithAnna LaucisBaris Turkbey Genitourinary Cancers (DP Petrylak and JW Kim, Section Editors) 05 March 2019 Article: 31
Evidence-Based Practice: Temozolomide Beyond Glioblastoma Jason ChuaElizabeth NafzigerDenise Leung Neuro-oncology (Y Umemura, Section Editor) 05 March 2019 Article: 30
Cardiovascular Complications Associated with Multiple Myeloma Therapies: Incidence, Pathophysiology, and Management Vivek G. PatelRobert F. Cornell Cardio-oncology (EH Yang, Section Editor) 05 March 2019 Article: 29